Compounds for reducing cholesterol and treating liver and kidney disease
AssigneeMcMaster University
InventorsJakob Magolan, Richard Austin, Paul Lebeau, Jae Hyun Byun, Paul Saliba, Matthew Sguazzin
Life of this patent
Estimating the term…
Abstract
This application relates to compounds such as compounds of Formula (I) that block SREBP2-induced hepatic PCSK9 expression, compositions comprising these compounds and methods of use thereof; for example, for treating diseases, disorders or conditions treatable by blocking SREBP2 activation and/or PCSK9 gene expression.
Claims33
A compound of Formula (Ia):
- or a pharmaceutically acceptable salt, solvate and/or prodrug thereof;
- wherein
- R1 is selected from
- (i) phenyl optionally substituted with one to five substituents independently selected from CN, halo, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H and C(O)H, and substituted with one or two of C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (ii) 9-10-membered bicyclic aryl wherein the second ring is phenyl or C5-6cycloalkyl and the 9-10 membered bicyclic aryl is optionally substituted with one or more substituents independently selected from ═O, CN, halo, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (iii) monocyclic C3-6cycloalkyl or C5-6cycloalkenyl optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (iv) 8-10-membered bicyclic cycloalkyl or cycloalkenyl wherein the second ring is C5-6heterocycloalkyl, phenyl, C5-6cycloalkyl or C5-6heteroaryl and the 8-10-membered bicyclic cycloalkyl or cycloalkenyl is optionally substituted with one or more substituents independently selected from halo, CN NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (v) monocyclic C5-6heterocycloalkyl optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (vi) 8-10-membered bicyclic heterocycloalkyl wherein the second ring is C5-6heterocycloalkyl, phenyl, C5-6cycloalkyl or C5-6heteroaryl and the 8-10-membered bicyclic heterocycloalkyl is optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (vii) monocyclic C5-6heteroaryl, optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- and
- (viii) 8-10-membered bicyclic heteroaryl wherein the second ring C5-6heterocycloalkyl, phenyl, C5-6cycloalkyl or C5-6heteroaryl and the 8-10-membered bicyclic heteroaryl is optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- R2 is selected from H, C1-6alkyl and C1-6alkyl substituted with one or more substituents independently selected from OH and halo;
- and
- X1 and X2 are independently selected from O, NH, N(C1-6alkyl), N(C1-6fluoroalkyl), C(O), C(O)O, OC(O), C(O)NH, C(O)N(C1-6alkyl), C(O)N(C1-6fluoroalkyl), NHC(O), N(C1-6alkyl)C(O), N(C1-6fluoroalkyl)C(O), S, S(O) and SO2;
- provided that R1 is not:
- (a) phenyl monosubstituted with unsubstituted phenyl, unsubstituted pyridinyl and unsubstituted pyrazolyl;
- (b) unsubstituted thiophenyl or thiophenyl substituted with Br, NO2, CN, CH3, C(O)H, C(O)CH3 or OCH3;
- (c) unsubstituted furanyl or furanyl substituted with Cl, Br, CH3, CF3, C(O)H or phenyl;
- (d) unsubstituted pyrimidinyl, unsubstituted pyridinyl or pyridinyl monosubstituted with NHCH3, Br, CH3 or pyridinyl;
- (e)
- wherein Y is NH, O or S, and when Y is, the phenyl ring is unsubstituted or mono-substituted with OCH3 or Cl;
- and
- (f)
(canceled)
-6. (canceled)
-11. (canceled)
-14. (canceled)
-18. (canceled)
(canceled)
(canceled)
-24. (canceled)
-27. (canceled)
-30. (canceled)
A compound selected from the compounds listed in Table 1 or a pharmaceutically acceptable salt, solvate and/or prodrug thereof.
A method of treating a disease, disorder or condition treatable by blocking SREBP2 activation and/or PCSK9 gene expression, the method comprising administering a therapeutically effective amount of one or more compounds of Formula (I), or a pharmaceutically acceptable salt, solvate and/or prodrug thereof, to a subject in need thereof:
- wherein
- R1 is selected from
- (i) phenyl substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (ii) 9-10-membered bicyclic aryl wherein the second ring is phenyl or C5-6cycloalkyl and the 9-10 membered bicyclic aryl is optionally substituted with one or more substituents independently selected from ═O, halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (iii) monocyclic C3-6cycloalkyl or C5-6cycloalkenyl optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (iv) 8-10-membered bicyclic cycloalkyl or cycloalkenyl wherein the second ring is C5-6heterocycloalkyl, phenyl, C5-6cycloalkyl or C5-6heteroaryl and the 8-10-membered bicyclic cycloalkyl or cycloalkenyl is optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (v) monocyclic C5-6heterocycloalkyl optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (vi) 8-10-membered bicyclic heterocycloalkyl wherein the second ring is C5-6heterocycloalkyl, phenyl, C5-6cycloalkyl or C5-6heteroaryl and the 8-10-membered bicyclic heterocycloalkyl is optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- (vii) monocyclic C5-6heteroaryl, optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- and
- (viii) 8-10-membered bicyclic heteroaryl wherein the second ring is C5-6heterocycloalkyl, phenyl, C5-6cycloalkyl or C5-6heteroaryl and the 8-10-membered bicyclic heteroaryl is optionally substituted with one or more substituents independently selected from halo, CN, NH2, OH, NO2, C1-6alkyl, C1-6fluoroalkyl, C1-6alkyleneOH, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)(C1-6alkyl), X1—C1-6alkyl, X1—C1-6fluoroalkyl, CO2H, C(O)H, C5-6heteroaryl, C5-6heterocycloalkyl, phenyl, X1-phenyl, C1-6alkylene-phenyl, X1—C1-6alkylenephenyl, C3-6cycloalkyl and C3-6cycloalkenyl, the latter 8 groups being optionally substituted with one or more substituents independently selected from halo, OH, C1-6alkyl, C1-6fluoroalkyl, X2—C1-6alkyl, X2—C1-6fluoroalkyl and NH2;
- R2 is selected from H, C1-6alkyl and C1-6alkyl substituted with one or more substituents independently selected from OH and halo;
- and
- X1 and X2 are independently selected from O, NH, N(C1-6alkyl), N(C1-6fluoroalkyl), C(O), C(O)O, OC(O), C(O)NH, C(O)N(C1-6alkyl), C(O)N(C1-6fluoroalkyl), NHC(O), N(C1-6alkyl)C(O), N(C1-6fluoroalkyl)C(O), S, S(O) and SO2.
-69. (canceled)
-80. (canceled)
(canceled)
Dependencies are inferred from the claim text.